• RN7SL1 may be translated under oncogenic conditions (PNAS, 2024)
  • High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer marker (Cancer Sci, 2024)
  • Fat and proteolysis due to methionine, tryptophan, and niacin deficiency leads to alterations in gut microbiota and immune modulation in inflammatory bowel disease (Cancer Sci, 2024)
  • The significance of signal recognition particle 9: implications for pancreatic cancer prognosis and functionality (Int J Oncol, 2024)
  • RNA methylation in inflammatory bowel disease (Cancer Sci, 2023)
  • The link of mRNA and rRNA transcription as a novel therapeutic target for cancer (Biomedicines, 2023)
  • Revealing neuropilin expression patterns in pancreatic cancer: from single-cell to therapeutic opportunities (Oncology Letters, 2023)
  • Systematic analysis and characterization of long non-coding RNA genes in inflammatory bowel disease (Briefing Function Genomic, 2023)
  • Drug discovery and development of miRNA-based nucleotide drugs for gastrointestinal cancer (Biomedicines, 2023)
  • Multifaced roles of desmoplastic reaction and fibrosis in pancreatic cancer progression (Cancer Science, 2023)
  • T2DB: a web database for long non-coding RNA genes in type II diabetes (Noncoding RNA, 2023)
  • The role of RNA methylation in the regulation of pancreatic cancer stem cells (Oncology Letters, 2023)
  • Cancer-specific tissue-resident memory T-cells in colorectal cancer (Br. J. Cancer, 2023)
  • m6 RNA methylation: An emerging common target in the immune response to cancer and severe acute respiratory syndrome-coronavirus-2 infection (Exp Med, 2022)
  • Emerging roles of long noncoding and circular RNAs in pancreatic ductal adenocarcinoma (Front Physiol, 2022)
  • Pancreatic cancer research beyond DNA mutations (Biomolecules, 2022)
  • Targeting the regulation of aberrant protein production pathway in gastrointestinal cancer treatment (Front Oncol, 2022)
  • Circulating cancer-associated extracellular vesicles as detection and recurrence biomarkers for pancreatic cancer (Cancer Science, 2022)
  • RNA Modification in Inflammatory Bowel Diseases (Biomedicines, 2022)
  • N6-methyladenosine methylation-regulated PLK1 cell cycle as a potential target of pancreatic adenocarcinoma (Scientific Reports, 2022)
  • Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma (iScience, 2022)
  • EpisomiR, a new family of miRNAs, and its possible roles in human diseases (Biomedicines, 2022)
  • Direct observation of DNA alterations induced by DNA disruptor (Scientific Reports, 2022)
  • Detection techniques for epitranscriptomic marks (Am J Physiol, 2022, in press)
  • Nematode applied technology for human tumor microenvironment research and development (Current Issues in Molecular Biology, 2022, in press)
  • Cancer metabolism challenges genomic instability and clonal evolution as therapeutic targets (Cancer Science, 2022)
  • Clinicopathological significance of MYL9 expression in pancreatic ductal adenocarcinoma (Cancer Rep., 2021)
  • Methylosystem for Cancer Sieging Strategy (Cancers 2021)
  • Single-Molecule RNA Sequencing for Simultaneous Detection of m6A and 5mC (Scientific Reports, 2021)
  • Computational healthcare, present and future perspectives (Experimental and Therapeutic Medicine, 2021, in press)
  • Scent test using Caenorhabditis elegans to screen for early-stage pancreatic cancer (Oncotarget, 2021, in press)
  • Epithelial cell transformation and senescence as indicators of genome aging: current advances and unanswered questions (Int. J. Mol. Sci., 2021, in press)
  • Impact of one-carbon metabolism-driving epitranscriptome as a therapeutic target for gastrointestinal cancer (Int. J. Mol. Sci., 2021, in press)
  • Reproducibility of CRISPR-Cas9 Methods for generation of conditional mouse alleles (Genome Biology, correspondence, 2021, in press)
  • Ribonucleotide base enzymes and diseases (Elsevier book, 2021, in press) A practical textbook for industry-academia collaboration will be published in English by Elsevier. As a result of our research, Dr. Konno et al. updated about ribonucleotide biochemistry.
  • The issues in epitranscriptomics and diseases were published in a Springer Book, 2021 (Editors, Drs. Stefan Jurga and Jan Barciszewski).
  • Collaborative research with Osaka International Cancer Institute and Kyushu University was accepted in Regenerative Therapy, 2021.
  • Graduate Student Dr. Yanagisawa’s paper was accepted in Biology, 2020.
  • Graduate Student Dr. Takeda’s paper was accepted in Cells, 2020.
  • A result of collaborative research for biodiagnosis was published in Book Chapter through industry-academia collaboration.
  • Associate Professor Masamitsu Konno’s paper was accepted for diagnosis with model organisms.
  • A result of collaborative research was accepted in Nat. Commun., 2020.
  • Graduate Student Dr. Yanagisawa’s paper was accepted in Int. J. Mol. Sci., 2020.
  • Assistant Professor Ayumu Asai’s paper was accepted in Int. J. Mol. Sci., 2020.
  • Assistant Professor Ayumu Asai’s paper was accepted in Oncotarget, 2020.
  • Assistant Professor Ayumu Asai’s paper was accepted in Cancer Letters (impact factor = 6.508), 2019 as an international collabolation research.
  • Graduate Student Dr. Tsunekuni’s paper was accepted in Scientific Reports, 2019.
  • Associate Professor Masamitsu Konno’s paper was accepted in Nature Communications, 2019.
  • International collaborative research was accepted in Genome Biology, 2019.
  • Assistant Professor Jun Koseki’s review was accepted in International cancer specialty books.
  • Graduate Student Dr. Ueda’s paper was accepted in Oncotarget, 2019.
  • Graduate Student Dr. Matsushita’s paper was accepted in ChemMedChem, 2019.
  • Associate Professor Masamitsu Konno’s Editorial on RNA modification in cancer was published in Cancer Science.
  • Collaborative research with Professor Taniguchi of the institue of scientific and
    industrial research was accepted in Scientific Reports, 2019.
    In addition, the research results (Direct observation of anti-cancer drug
    by Single molecule sequencer for the first time in the world) were press released.
    http://resou.osaka-u.ac.jp/ja/research/2019/20190307_1
    https://www.sanken.osaka-u.ac.jp/toppage/hot_topics/topics_20190307/
    https://www.jst.go.jp/pr/announce/20190307/index.html
  • Graduate Student Dr. Takaoka’s paper was accepted in Cancer Science, 2019.
  • Collaborative research with Gastrointestinal Surgery in Osaka University was accepted in Cancer Research, 2019.
  • Collaborative research with Professor Gotoh of Kanazawa University was accepted in PNAS, 2019.
  • Associate Professor Masamitsu Konno’s Editorial on artificial intelligence was published in Oncotarget.
  • Dr. Asai’s paper was accepted in Heliyon, in press.
  • Graduate student Dr. Tamari’s paper (graduate; Assistant Professor of Radiotherapy Department) was accepted in Cell Death Discovery.
  • Graduate Student Dr. Toratani’s paper was accepted in Cancer Research, in press.
  • Graduate Student Dr. Toshiyama’s paper was accepted in Oncogene, in press.
  • Associate Professor Masamitsu Konno’s paper was accepted in Scientific Reports, in press.
  • Assistant Professor Jun Koseki’s paper was accepted in Scientific Reports, in press.
  • Graduate Student Dr. Toshiyama’s paper was accepted in Oncology Letters, in press.
  • Graduate Student Dr. Ohhashi’s paper was accepted in Oncology Reports, in press.
  • Graduate Student Dr. Nishizawa’s paper was accepted in Oncotarget, in press.
  • Graduate Student Dr. Nishizawa’s paper was accepted in Int J Oncol, in press.
  • Graduate Student Dr. Taketoh’s paper was accepted in Int J Oncol, in press.
  • Associate Professor Konno, the Best Award Winner: the Best Poster Award at the Platform of Advanced Animal Model Support Grant-in-Aid for Scientific Research on the Innovative Areas was given to him.
  • Graduate Student Dr. Tsunekuni’s paper was accepted in Oncotarget, 2017.
  • Graduate Dr. Asukai’s paper was accepted in Annal. Surg. Oncol., 2017.
  • Graduate Student M.D. Baek’s paper was accepted in Oncol. Rep., 2016.
  • Graduate Dr. Miyo’s paper was accepted in Sci. Rep., 2016.
  • Assistant Professor Masamitsu Konno’s paper was accepted in Int. J. Oncology, 2017.
  • Graduate Student M.D. Hugh Colvine’s paper was accepted in Sci. Rep., 2016.
  • Assistant Professor Koich Kawamoto’s paper was accepted in Oncology Reports, 2016.
  • Graduate Dr. Miyo’s paper was accepted in Oncol. Rep., 2016.
  • Graduate Student M.D. Nishizawa’s paper was accepted in Annal. Surg. Oncology, 2016.
  • Graduate Student M.D. Noguchi’s paper was accepted in Oncol. Lett, 2016.
  • Graduates Dr. Ogawa’s paper was accepted in Biomedical Rep., 2016.
  • Assistant Professor Jun Koseki’s paper was accepted in Scientific Reports, 2016.
  • Graduate Student M.D. Sueda’s paper was accepted in Scientific Reports, 2016.
  • Graduate Dr. Hasegawa’s paper was accepted in Int. J. Oncology, 2015.
  • Assistant Professor Masamitsu Konno’s paper was accepted in PLOS ONE, 2015.
  • Graduate Student M.D. Asukai’s paper was accepted in Annal. Surg. Oncology, 2015.
  • Graduate Student M.D. Baek’s paper was accepted in Oncology Rep., 2015.
  • Graduate Student M.D. Noguchi’s paper was accepted in Cancer Sci., 2015.
  • Graduate Student M.D. Miyo’s paper was accepted in Br. J. Cancer, 2015.
  • Graduates M.D. Ogawa’s paper was accepted in PLOS ONE., 2015.
  • Graduates Dr. Nishikawa’s paper was accepted in Onlol. Rep., 2015.
  • Assistant Professor Masamitsu Konno’s paper was accepted in Regen. Therap., 2014.
  • Graduate Student M.D. Ogawa’s paper was accepted in Oncol. lett., 2014.
  • Graduate Student M.D. Hasegawa’s paper was accepted in Oncol. lett., 2014.
  • Assistant Professor Jun Koseki’s paper was accepted in Int. J. Oncol, 2014.
  • Graduate Student M.D. Hamabe’s paper was accepted in PNAS, 2014.
  • Graduate Student M.D. Colvin’s paper review was accepted in JJCO, 2014.
  • Graduate Student M.D. Hayashi’s paper was accepted in Int. J. Oncol, 2014.
  • Graduate Student M.D. Tamari’s paper was accepted in Int. J. Oncol, 2014.
  • Assistant Professor Koichi Kawamoto’s paper was accepted in J Stem Cell Res Ther, 2014.
  • Graduate Student M.D. Hasegawa’s paper was accepted in Br. J. Cancer, 2014.
  • Graduate Student M.D. Hamabe’s paper was accepted in Cancer Sci., 2014.
  • Graduate Student M.D. Fukusumi’s paper was accepted in Br. J. Cancer, 2014.